Terbutaline (CID 5403) - BioAssay Data Summary for Compound
.
BioActivity Outcomes:
Active(7)
 
 
Inactive(65)
 
 
Inconclusive(21)
 
 
Unspecified(234)
 
 
Top Targets:
7TM GPCR Srsx(18)
 
 
 
 
7TM GPCR Srx(16)
 
 
 
p450(8)
 
 
Pyr redox dim(4)
 
 
PIKKc TOR(4)
 
 
BioAssay Types:
Literature(124)
 
 
 
 
 
Confirmatory(53)
 
 
 
Screening(12)
 
 
BioActivity Types:
IC50(132)
 
 
 
Potency(53)
 
 
 
Kd(1)
 
 
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 326    Data Row: 327   Total Pages: 7   Display: Page     
Sort: [Click the result table header to sort]
#SubstanceActivityBioAssayTargetLinks
OutcomeTypeValue [μM]
1
[SID103709193]
Kd 2.51Binding affinity to human adrenergic beta2 receptor [AID426242, Type: Literature]Beta-2 adrenergic receptor [gi:296439450]
View
2
[SID103709193]
Kd 2.51Binding affinity to human adrenergic beta2 receptor [AID426242, Type: Literature]Beta-2 adrenergic receptor [gi:296439450]
View
3
[SID103709193]
Kd 2.51Binding affinity to human adrenergic beta2 receptor [AID426242, Type: Literature]Beta-2 adrenergic receptor [gi:296439450]
View
4
[SID103709193]
Kd 2.51Binding affinity to human adrenergic beta2 receptor [AID426242, Type: Literature]Beta-2 adrenergic receptor [gi:296439450]
View
5
[SID48414500]
DSSTox (CPDBAS) Carcinogenic Potency Database Summary Rat Bioassay Results [AID1208, Type: other]
View
6
[SID48414500]
DSSTox (CPDBAS) Carcinogenic Potency Database Summary SingleCellCall Results [AID1189, Type: other]
View
7
[SID85209330]
Ligands of bioamine (Class A) GPCRs [AID2062, Type: other]
View
8
[SID48416600]
DSSTox (FDAMDD) FDA Maximum (Recommended) Daily Dose Database [AID1195, Type: other]
View
9
[SID103709193]
Affinity for cow beta-2 adrenergic receptor by measuring displacement (-)-[3H]dihydroalprenolol (DHA) [AID40694, Type: Literature]
View
10
[SID103709193]
Apparent binding affinity constant to beta-2 adrenergic receptor determined using [3H]DHA [AID40687, Type: Literature]Beta-2 adrenergic receptor [gi:2851541]
View
11
[SID103709193]
ED50 1.04e+06Compound was tested for effective dose required for 50% of maximum response in guinea pig trachea [AID76656, Type: Literature]
View
12
[SID103709193]
Intrinsic activity (n=5) in guinea pig trachea [AID77606, Type: Literature]
View
13
[SID103709193]
Partition coefficient (logD7.4) [AID19419, Type: Literature]
View
14
[SID103709193]
Human absorption A (%) [AID20050, Type: Literature]
View
15
[SID103709193]
Effective permeability measured in human. [AID21264, Type: Literature]
View
16
[SID103709193]
Intrinsic activity in guinea pig trachea [AID77607, Type: Literature]
View
17
[SID103709193]
Binding to POPC (palmitoyl-oleolyl-phosphatidyl-choline) liposomes using biosensor system [AID156089, Type: Literature]
View
18
[SID103709193]
Binding to POPC/GMI liposomes using biosensor system [AID156203, Type: Literature]
View
19
[SID103709193]
Change in Gibb's free energy at Low affinity beta-2-adrenoreceptor in the membranes of bovine skeletal muscle preparation [AID218845, Type: Literature]
View
20
[SID103709193]
Change in Gibb's free energy at High affinity beta2- adrenoceptor in Chang living cells. [AID218847, Type: Literature]
View
21
[SID103709193]
Change in Gibb's free energy at Low affinity beta-2-adrenoreceptor in the Chang living cells [AID218848, Type: Literature]
View
22
[SID103709193]
Fraction absorbed in human intestine after oral administration compound was measured [AID236268, Type: Literature]
View
23
[SID103709193]
Permeability Coefficient in 2/4/A1 cell model [AID236912, Type: Literature]
View
24
[SID103709193]
Permeability Coefficient in Caco-2 cell culture model [AID236913, Type: Literature]
View
25
[SID103709193]
Permeability Coefficient in hexadecane membranes model [AID236914, Type: Literature]
View
26
[SID103709193]
Percentage of mass balance in hexadecane membranes model [AID236916, Type: Literature]
View
27
[SID103709193]
Clearance in human [AID310711, Type: Literature]
View
28
[SID103709193]
Fraction unbound in human plasma [AID444050, Type: Literature]
View
29
[SID103709193]
Total clearance in human [AID444051, Type: Literature]
View
30
[SID103709193]
Hepatic clearance in human [AID444052, Type: Literature]
View
31
[SID103709193]
Renal clearance in human [AID444053, Type: Literature]
View
32
[SID103709193]
Oral bioavailability in human [AID444054, Type: Literature]
View
33
[SID103709193]
Fraction absorbed in human [AID444055, Type: Literature]
View
34
[SID103709193]
Fraction escaping gut-wall elimination in human [AID444056, Type: Literature]
View
35
[SID103709193]
Fraction escaping hepatic elimination in human [AID444057, Type: Literature]
View
36
[SID103709193]
Volume of distribution at steady state in human [AID444058, Type: Literature]
View
37
[SID103709193]
Permeability at pH 6.5 by PAMPA method [AID445445, Type: Literature]
View
38
[SID103709193]
Oral bioavailability in human [AID445446, Type: Literature]
View
39
[SID103709193]
Unbound fraction (plasma) [AID7783, Type: Literature]
View
40
[SID103709193]
Observed volume of distribution [AID8002, Type: Literature]
View
41
[SID103709193]
Calculated partition coefficient (clogP) [AID15711, Type: Literature]
View
42
[SID103709193]
Estimation of fraction absorbed (Fa) in the human intestine using biosensor technology. [AID18849, Type: Literature]
View
43
[SID103709193]
GOF value represents multisets of log P data [AID18861, Type: Literature]
View
44
[SID103709193]
Delta logD (logD6.5 - logD7.4) [AID22293, Type: Literature]
View
45
[SID103709193]
log(1/ISA) value of the compound [AID24177, Type: Literature]
View
46
[SID103709193]
Distribution coefficient in octanol/water at pH 5.5 [AID24202, Type: Literature]
View
47
[SID103709193]
Distribution coefficient in octanol/water at pH 6.5 [AID24203, Type: Literature]
View
48
[SID103709193]
Distribution coefficient in octanol/water at pH 7.4 [AID24204, Type: Literature]
View
49
[SID103709193]
Partition coefficient (logP) [AID24420, Type: Literature]
View
50
[SID103709193]
Calculated partition coefficient (clogP) [AID24440, Type: Literature]
View